Table 2:
SEP-atopic dermatitis associations by study characteristic
| Total | |||||
|---|---|---|---|---|---|
| 37 (42%) | 13 (15%) | 23 (26%) | 15 (17%) | 88 | |
| Region | |||||
| Africa/Middle East | 3 (25%) | 2 (17%) | 3 (25%) | 4 (33%) | 12 |
| Asia | 10 (45%) | 5 (23%) | 4 (18%) | 3 (14%) | 22 |
| Europe | 22 (51%) | 2 (5%) | 14 (32%) | 5 (12%) | 43 |
| Americas | 2 (20%) | 4 (40%) | 1 (10%) | 3 (30%) | 10 |
| Oceania | 0 | 0 | 1 (100%) | 0 | 1 |
| Study Design | |||||
| Case-Control | 3 (43%) | 1 (14%) | 2 (29%) | 1 (14%) | 7 |
| Cohort | 9 (41%) | 3 (14%) | 8 (36%) | 2 (9%) | 22 |
| Cross-Sectional | 25 (43%) | 9 (15%) | 13 (22%) | 12 (20%) | 59 |
| Age Group | |||||
| Adults | 3 (30%) | 1 (10%) | 3 (30%) | 3 (30%) | 10 |
| Both | 3 (30%) | 3 (30%) | 3 (30%) | 1 (10%) | 10 |
| Children | 31 (46%) | 9 (13%) | 17 (25%) | 11 (16%) | 68 |
| Method of Atopic Dermatitis Assessment | |||||
| Exam | 2 (22%) | 1 (11%) | 4 (45%) | 2 (22%) | 9 |
| Self-Report | 31 (46%) | 9 (14%) | 15 (22%) | 12 (18%) | 67 |
| Medical Record | 4 (33%) | 3 (25%) | 4 (33%) | 1 (9%) | 12 |
| Sample Size | |||||
| 20000+ | 14 (46%) | 6 (19%) | 3 (12%) | 6 (23%) | 29 |
| 2500–19999 | 15 (50%) | 2 (7%) | 9 (30%) | 4 (13%) | 30 |
| 105–2499 | 8 (28%) | 5 (17%) | 11 (38%) | 5 (17%) | 29 |
| Publication Date | |||||
| 1975–1989 | 3 (43%) | 0 | 0 | 4 (57%) | 7 |
| 1990–1999 | 7 (88%) | 0 | 0 | 1 (12%) | 8 |
| 2000–2009 | 11 (46%) | 2 (8%) | 4 (17%) | 7 (29%) | 24 |
| 2010–2019 | 16 (33%) | 14 (29%) | 10 (20%) | 9 (18%) | 49 |